TORNTPHARM Intraday Analysis...

TORNTPHARM Share Price

Open 1361.95 Change Price %
High 1362.40 1 Day -2.50 -0.19
Low 1335.60 1 Week -33.40 -2.43
Close 1343.75 1 Month 10.45 0.78
Volume 85673 1 Year -131.85 -8.94
52 Week High 1769.50
52 Week Low 1189.00
TORNTPHARM Important Levels
Resistance 2 1368.59
Resistance 1 1358.36
Pivot 1347.25
Support 1 1329.14
Support 2 1318.91
NSE INDIA Most Active Stocks
ADANIPOWER 31.80 -1.40%
UNITECH 4.70 0.00%
FEDERALBNK 69.20 -0.93%
SBIN 255.60 -1.35%
NATIONALUM 69.25 12.15%
TATAPOWER 74.30 -1.20%
HCC 39.45 0.90%
HCC 39.45 0.90%
VISESHINFO 0.35 16.67%
SUNPHARMA 664.00 -5.97%
More..
NSE INDIA Top Gainers Stocks
FARMAXIND 0.15 50.00%
NBIFIN 270.00 25.00%
PARASPETRO 0.25 25.00%
VIJIFIN 16.20 20.00%
ARCHIES 27.60 20.00%
KARMAENG 54.70 19.96%
VISESHINFO 0.35 16.67%
AUSTRAL 0.35 16.67%
SUJANAUNI 2.15 16.22%
ORICONENT 53.80 14.59%
More..
NSE INDIA Top Losers Stocks
BIRLACOT 0.05 -50.00%
RASOYPR 0.15 -25.00%
KSERASERA 0.15 -25.00%
PRADIP 1.90 -19.15%
FCSSOFT 0.25 -16.67%
RELIGARE 244.95 -8.69%
SHYAMTEL 35.40 -7.93%
VASWANI 9.30 -7.92%
BARTRONICS 16.50 -7.30%
LOTUSEYE 27.70 -6.73%
More..

Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)

TORNTPHARM Technical Analysis 3
As on 7th Dec 2016 TORNTPHARM Share Price closed @ 1343.75 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1425.71 & Sell for SHORT-TERM with Stoploss of 1481.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
TORNTPHARM Target for December
1st Target up-side 1525.31
2nd Target up-side 1629.15
3rd Target up-side 1733
1st Target down-side 1228.99
2nd Target down-side 1125.15
3rd Target down-side 1021.3
TORNTPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 43.88 Sideways
MFI (14) MFI is 57.73 Sideways
CCI (20) CCI is 26.18 Sideways
WILLIAM %R (14) William %R is -48.69 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1450.83
10 Day Avg Volume Traded -43.91 % Less then 10 Day Average Volume
TORNTPHARM Other Details
Segment EQ
Market Capital 16629527552.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.torrentpharma.com
TORNTPHARM Address
TORNTPHARM
Off. Ashram Road
Ahmedabad, 380009
India
Phone: 91 79 2658 5090
Fax: 91 79 2658 2100
Interactive Technical Analysis Chart Torrent Pharmaceuticals Limited ( TORNTPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Torrent Pharmaceuticals Limited
TORNTPHARM Business Profile
Torrent Pharmaceuticals Limited, a pharmaceutical company, engages in the manufacture and sale of branded and unbranded generic pharmaceutical products. The company offers its products primarily in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective, and pain management therapeutic areas. It offers products in the form of tablets, capsules, and parenterals. The company’s active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate; and level 1 area products include atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. It is also involved in the provision of contract manufacturing services primarily for human insulin. Torrent Pharmaceuticals Limited primarily sells its products in India, the United States, Brazil, Europe, Russia, the Asia Pacific, Africa, and CIS countries. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. Torrent Pharmaceuticals Limited was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Ltd operates as a subsidiary of Torrent Private Limited.